NEU 3.50% $14.05 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1331

  1. 1,239 Posts.
    lightbulb Created with Sketch. 317
    agree if NEU is following through phase 3 and subsequently decides to do a licensing deal (which is unlikely in my view), the terms would be substantially better than Acadia's. The company quoted $50-$100m AUD not USD for a phase 3 trail which is comparable to what E&P estimated at USD $40m (they simply use the mid point)
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$14.05
Change
-0.510(3.50%)
Mkt cap ! $1.795B
Open High Low Value Volume
$14.38 $14.42 $13.94 $6.419M 454.6K

Buyers (Bids)

No. Vol. Price($)
1 500 $13.99
 

Sellers (Offers)

Price($) Vol. No.
$14.07 6644 4
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.